Werfen Academy exceeds 20,000 users milestone WorldWide
Today, let’s celebrate all together an exciting new milestone for Werfen Academy: 20,000 users Worldwide. Congratulations everyone!
Since its launch, Werfen Academy users have enrolled in more than 178,000 courses, covering Hemostasis, Acute Care and Autoimmunity. Highest enrollments include operator training for the ACL TOP Family 50 Series, GEM Premier 5000, ROTEM sigma, BIO-FLASH, as well as educational courses in Hemophilia, Anticoagulation Monitoring, Preanalytical Issues, and Antiphospholipid Syndrome.
EEMEA Statistics
As EEMEA, we’re currently 1425 people enjoying the platform and its fascinating courses, from almost 80 different countries. But let’s take a closer look:


GEM and Oxygenation are still leading the rankings, but PT and APTT Curve interpretation on ACL TOP seems to spark a lot of interest among our EEMEA users.
Newest Releases
HEMOSTASIS
- Anticoagulation in Special Situations - Kelly Rudd, PharmD, FCCP, BCPS, CACP.
- Unexplained Arterial Thromboembolism: Approach to Diagnosis and Treatment - Jori May, MD; Arthur L. Allen, PharmD, CACP; Deborah Siegal, MD, MSc, FRCPC; Andrea Van Beek, RN, DNP, AGPCNP-BC.
- Common Indications for Anticoagulation: Venous Thromboembolism - Adam Cuker, MD, MS.
- Four new operator training courses for HemoHub™ Intelligent Data Manager
ACUTE CARE DIAGNOSTICS
- and TEG as a Resource in the Hemostatic Management in the Inpatient - Marino Sol Lopez, MD and David Faraoni, MD, PhD.
Congratulations to all the Werfen Academy teams who have effectively promoted the value of Werfen Academy to our customers!
Remember to re-share the latest LinkedIn post for Werfen Academy: LINK
Looking forward to leverage more and more on Werfen Academy,
Werfen Academy Team



